Scarica l'app Stockscreener
35.35
0.23%
-0.59
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché TVTX Giù?
Forum
Previsione
Frazionamento azionario
Travere Therapeutics Inc Borsa (TVTX) Ultime notizie
Squarepoint Ops LLC Grows Position in Travere Therapeutics, Inc. $TVTX - MarketBeat
Frazier Life Sciences Management L.P. Makes New Investment in Travere Therapeutics, Inc. $TVTX - MarketBeat
Birchview Capital LP Trims Stake in Travere Therapeutics, Inc. $TVTX - MarketBeat
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)December 11, 2025 - BioSpace
Trading Systems Reacting to (TVTX) Volatility - news.stocktradersdaily.com
Federated Hermes Inc. Sells 145,110 Shares of Travere Therapeutics, Inc. $TVTX - MarketBeat
Travere Therapeutics (NASDAQ: TVTX) issues 20,300 new-hire RSUs vesting over four years - Stock Titan
742,725 Shares in Travere Therapeutics, Inc. $TVTX Acquired by Marshall Wace LLP - MarketBeat
Ligand Hosts 2025 Investor Day and Introduces 2026 Guidance - GlobeNewswire Inc.
Schroder Investment Management Group Decreases Position in Travere Therapeutics, Inc. $TVTX - MarketBeat
Capital Fund Management S.A. Acquires Shares of 101,406 Travere Therapeutics, Inc. $TVTX - MarketBeat
Travere Therapeutics (NASDAQ:TVTX) CFO Christopher Cline Sells 20,000 Shares - MarketBeat
Panagora Asset Management Inc. Buys 96,062 Shares of Travere Therapeutics, Inc. $TVTX - MarketBeat
Travere Therapeutics CFO Sells 20,000 Shares - TradingView
Loomis Sayles & Co. L P Trims Position in Travere Therapeutics, Inc. $TVTX - MarketBeat
Travere Therapeutics (NASDAQ:TVTX) Is Carrying A Fair Bit Of Debt - 富途牛牛
Legal & General Group Plc Boosts Stake in Travere Therapeutics, Inc. $TVTX - MarketBeat
Travere Therapeutics, Inc. (TVTX) Investigation: Bronstein, Gewir - The National Law Review
Travere Therapeutics (TVTX) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Evercore Healthcare Conference - MarketScreener
The Insider Report: The Dip Was Bought Before the Holidays - Benzinga
Virtus Investment Advisers LLC Buys 9,699 Shares of Travere Therapeutics, Inc. $TVTX - MarketBeat
F m Investments LLC Has $2.78 Million Stock Position in Travere Therapeutics, Inc. $TVTX - MarketBeat
Travere Therapeutics (NASDAQ:TVTX) Downgraded to "Buy" Rating by Wall Street Zen - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review
Is Travere Therapeutics Inc. stock a contrarian buyJuly 2025 Fed Impact & Verified Entry Point Signals - BỘ NỘI VỤ
Bronstein, Gewirtz & Grossman, LLC Is Investigating Travere Thera - The National Law Review
Travere Therapeutics (NASDAQ:TVTX) Reaches New 52-Week HighHere's Why - MarketBeat
HC Wainwright Reiterates "Buy" Rating for Travere Therapeutics (NASDAQ:TVTX) - MarketBeat
Intech Investment Management LLC Cuts Stake in Travere Therapeutics, Inc. $TVTX - MarketBeat
Travere Therapeutics, Inc. $TVTX Shares Bought by Geode Capital Management LLC - MarketBeat
SG Americas Securities LLC Purchases Shares of 31,926 Travere Therapeutics, Inc. $TVTX - MarketBeat
Travere Therapeutics, Inc. 2025 Q3ResultsEarnings Call Presentation (NASDAQ:TVTX) 2025-11-29 - Seeking Alpha
Travere Therapeutics stock hits 52-week high at 37.12 USD By Investing.com - Investing.com Nigeria
Travere Therapeutics stock hits 52-week high at 37.12 USD - Investing.com
TVTX: HC Wainwright Reiterates Buy Rating and Maintains Price Ta - GuruFocus
HC Wainwright & Co. Reiterates Travere Therapeutics (TVTX) Buy Recommendation - Nasdaq
A Look at Travere Therapeutics’s Valuation Following FDA Updates Boosting FILSPARI’s Accessibility and Growth Prospects - Sahm
Travere Therapeutics, Inc. $TVTX Stake Lowered by Universal Beteiligungs und Servicegesellschaft mbH - MarketBeat
How Travere Therapeutics Inc. stock reacts to bond yieldsWeekly Stock Recap & AI Driven Stock Movement Reports - BỘ NỘI VỤ
How Travere Therapeutics Inc. stock trades during market volatilityWeekly Stock Analysis & Safe Entry Trade Reports - moha.gov.vn
Travere Therapeutics: Thriving Kidney Franchise Set To Soar On January PDUFA (TVTX) - Seeking Alpha
Ensign Peak Advisors Inc Increases Stock Holdings in Travere Therapeutics, Inc. $TVTX - MarketBeat
How institutional buying supports Travere Therapeutics Inc. stockMarket Trend Summary & Daily Profit Maximizing Trade Tips - newser.com
Will Travere Therapeutics Inc. stock maintain dividend yieldWeekly Earnings Recap & Real-Time Chart Breakout Alerts - newser.com
Is Travere Therapeutics Inc. stock trading at a premium valuationWeekly Loss Report & AI Driven Price Predictions - newser.com
Is Travere Therapeutics Inc. stock in correction or buying zoneJuly 2025 Fed Impact & Real-Time Chart Pattern Alerts - newser.com
(TVTX) and the Role of Price-Sensitive Allocations - news.stocktradersdaily.com
What makes Travere Therapeutics Inc. stock attractive to growth funds2025 Top Decliners & Expert Approved Trade Ideas - newser.com
What indicators show strength in Travere Therapeutics Inc.July 2025 Price Swings & AI Powered Market Trend Analysis - newser.com
What momentum shifts mean for Travere Therapeutics Inc.2025 Technical Overview & Safe Capital Growth Stock Tips - newser.com
Can Travere Therapeutics Inc. stock deliver strong Q4 earningsPortfolio Risk Report & Weekly Watchlist of Top Performers - newser.com
How Travere Therapeutics Inc. stock compares to industry benchmarksQuarterly Performance Summary & Weekly Breakout Stock Alerts - newser.com
0.42%
0.32%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):